New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENI... (@dsus.com kwix@dsus.com ...)

HOME >> MEDICINE >> TECHNOLOGY

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R)

Date:5/14/2008

@dsus.com">kwix@dsus.com rsalem@dsus.com

1. JNC 7 = The Seventh Report of the Joint National Committee on

Prevention, Detection, Evaluation and Treatment of High Blood Pressure

(JNC 7), which issued new guidelines in 2003 for hypertension

prevention and management.

2. http://www.americanheart.org/presenter.jhtml?identifier=4621 Site

accessed 4/18/2008

3. Kearney, P. et al. "Global Burden of Hypertension: Analysis of

Worldwide Data." Lancet 2005: 365: 217-23

4. http://www.americanheart.org/presenter.jhtml?identifier=2114 Site

accessed 4/18/2008

5. http://www.americanheart.org/presenter.jhtml?identifier=4621 Site

accessed 4/18/2008

0

GOOD

Page: 1 2 3 4 5 6 7
Related medicine technology :

1. Ceremeds OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows
2. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
3. St. Jude Study Shows How T Cells Machinery Dials Down Autoimmunity
4. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
5. NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life in Phase 1 Clinical Data Presented at American Pain Society Meeting
6. Study Shows Physician Judgment is Important in Reducing Rate of RSV-Related Hospitalizations Among High-Risk Infants
7. Community Breast Center Experience Shows Real-World Application of Breast-Specific Gamma Imaging Has Significant Impact on Clinical Care
8. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
9. FTY720, a novel oral therapy in development for MS, shows sustained benefits for the majority of patients after three years of treatment
10. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
11. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer

Post Your Comments:

New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENI...(@dsus.com kwix@dsus.com ...),Health